文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

德尔塔和奥密克戎疫情阶段新冠病毒疾病的病死率:一项荟萃分析。

The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.

作者信息

Kim Kisong, Cho Kyuyeon, Song Junmin, Rahmati Masoud, Koyanagi Ai, Lee Seung Won, Yon Dong Keon, Il Shin Jae, Smith Lee

机构信息

Yonsei University College of Medicine, Seoul, Republic of Korea.

Keimyung University School of Medicine, Daegu, Republic of Korea.

出版信息

J Med Virol. 2023 Feb;95(2):e28522. doi: 10.1002/jmv.28522.


DOI:10.1002/jmv.28522
PMID:36691933
Abstract

As coronavirus variants are constantly occurring, we tried to understand more about the omicron and delta variants that have hit the world. We provided dynamic information on the case fatality rate (CFR) of the Omicron variant over time and to compare it with that of the Delta variant through meta-analysis. Twenty-four countries were selected by submission counts, submission dates, and confirmed cases. We defined the Delta or the Omicron epidemic period for individual countries as when each variant is over 90%. We further analyzed the Omicron period by dividing it into the initial plateau, increasing, and decreasing phases according to the number of newly confirmed daily cases. Finally, the meta-analysis examined the summary and between-study heterogeneity. The CFR of COVID-19 during the Omicron epidemic was lower than that during the Delta epidemic (odds ratio [OR]: 0.252, 95% confidence interval [CI] 0.205-0.309). The CFR of COVID-19 during the initial plateau phase of Omicron was higher than during other phases. (OR: 1.962, 95% CI 1.607-2.397). The CFR of COVID-19 during the increasing phase was lower than during the decreasing phases (OR: 0.412, 95% CI 0.342-0.498). The Omicron variant had lower CFR compared to the Delta variant, and the initial plateau phase had higher CFR compared to the noninitial phases. These results can help establish global health policies for COVID-19 in the future.

摘要

由于新冠病毒变种不断出现,我们试图更深入地了解席卷全球的奥密克戎变种和德尔塔变种。我们提供了奥密克戎变种随时间变化的病死率动态信息,并通过荟萃分析将其与德尔塔变种的病死率进行比较。根据提交数量、提交日期和确诊病例数,选择了24个国家。我们将各个国家的德尔塔或奥密克戎流行期定义为每个变种占比超过90%的时期。我们根据每日新增确诊病例数将奥密克戎时期进一步分为初始平台期、上升期和下降期。最后,荟萃分析检验了汇总结果和研究间的异质性。奥密克戎流行期间新冠病毒病的病死率低于德尔塔流行期间(优势比[OR]:0.252,95%置信区间[CI] 0.205 - 0.309)。奥密克戎初始平台期新冠病毒病的病死率高于其他阶段(OR:1.962,95% CI 1.607 - 2.397)。新冠病毒病上升期的病死率低于下降期(OR:0.412,95% CI 0.342 - 0.498)。与德尔塔变种相比,奥密克戎变种的病死率较低,且初始平台期的病死率高于非初始阶段。这些结果有助于未来制定全球新冠病毒病防控政策。

相似文献

[1]
The case fatality rate of COVID-19 during the Delta and the Omicron epidemic phase: A meta-analysis.

J Med Virol. 2023-2

[2]
Differences in incidence and fatality of COVID-19 by SARS-CoV-2 Omicron variant versus Delta variant in relation to vaccine coverage: A world-wide review.

J Med Virol. 2023-1

[3]
A chronological review of COVID-19 case fatality rate and its secular trend and investigation of all-cause mortality and hospitalization during the Delta and Omicron waves in the United States: a retrospective cohort study.

Front Public Health. 2023

[4]
[Effect of the Omicron variant on cumulative incidence of infection and lethality during the sixth wave of the COVID-19 epidemic in Spain].

Semergen. 2024-3

[5]
Rapid review and meta-analysis of serial intervals for SARS-CoV-2 Delta and Omicron variants.

BMC Infect Dis. 2023-6-26

[6]
Clinical Characteristics and Risk Factors for Mortality in Critical COVID-19 Patients Aged 50 Years or Younger During Omicron Wave in Korea: Comparison With Patients Older Than 50 Years of Age.

J Korean Med Sci. 2023-7-17

[7]
A global analysis of COVID-19 infection fatality rate and its associated factors during the Delta and Omicron variant periods: an ecological study.

Front Public Health. 2023

[8]
A comparative study on epidemiological characteristics, transmissibility, and pathogenicity of three COVID-19 outbreaks caused by different variants.

Int J Infect Dis. 2023-9

[9]
Association Between 3 Doses of mRNA COVID-19 Vaccine and Symptomatic Infection Caused by the SARS-CoV-2 Omicron and Delta Variants.

JAMA. 2022-2-15

[10]
A comprehensive genomic study, mutation screening, phylogenetic and statistical analysis of SARS-CoV-2 and its variant omicron among different countries.

J Infect Public Health. 2022-8

引用本文的文献

[1]
Modulation of COVID-19 incidence by environmental stressors is variant between pre-Omicron and Omicron periods.

Sci Rep. 2025-7-29

[2]
Exploring the Replication and Pathogenic Characteristics of Alpha, Delta, and Omicron Variants of SARS-CoV-2.

Int J Mol Sci. 2024-11-25

[3]
The Impact of Healthcare Pressures on the COVID-19 Hospitalisation Fatality Risk in England.

J Epidemiol Glob Health. 2024-12

[4]
Tracking temporal variations of fatality and symptomology correlated with COVID-19 dominant variants and vaccine effectiveness in the United States.

Front Public Health. 2024

[5]
An assessment of excess mortality during the COVID-19 pandemic, a retrospective post-mortem surveillance in 12 districts - Zambia, 2020-2022.

BMC Public Health. 2024-9-27

[6]
Evolving patterns of COVID-19 mortality in US counties: A longitudinal study of healthcare, socioeconomic, and vaccination associations.

PLOS Glob Public Health. 2024-9-10

[7]
The effect of quarantine policy on pollution emission and the usage of private transportation in urban areas.

Sci Rep. 2024-7-8

[8]
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study.

J Nephrol. 2024-7

[9]
Global age-sex-specific mortality, life expectancy, and population estimates in 204 countries and territories and 811 subnational locations, 1950-2021, and the impact of the COVID-19 pandemic: a comprehensive demographic analysis for the Global Burden of Disease Study 2021.

Lancet. 2024-5-18

[10]
Evaluation of SARS-CoV-2 Vaccine-Induced Antibody Responses in Patients with Neuroimmunological Disorders: A Real-World Experience.

Diagnostics (Basel). 2024-2-26

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索